Neurocentrx, a United Kingdom-based pharmaceutical company, has named Nigel Brooksby as its non-executive chairman, it was reported on Friday.
Brooksby has experience in business and growth strategy across the healthcare sector having held senior global positions at Pfizer, Sanofi and Wellcome and now GSK. His career history has seen him work in private equity and venture capital and he has been president of the ABPI.
Brooksby said, 'My focus is to accelerate the business model and drive commercial clinical trials to raise international awareness of what we are offering, and enter the global market. I look forward to working the team, and helping to drive the company to an exciting new stage in their development.'
Convergent Therapeutics names new chairman of board of directors
Ionis Pharmaceuticals names new executive vice president, chief global product strategy officer
Cardinal Health names new independent director
Micron Biomedical names new scientific advisor to CEO
MedPharm names new executive chairman
Armonica Technologies names new director
Jazz Pharmaceuticals names new executive vice president and chief financial officer
Jazz Pharmaceuticals names new executive vice president and chief financial officer
Ardigen names new chief commercial officer
AbbVie names new chief executive officer
AMO Pharma collaborates with Population Health Research Institute for tideglusib clinical trial